The WVU Cancer Institute is making progress in combatting West Virginia’s lung cancer problem and recently attended the annual Bristol-Myers Squibb Foundation Grantee Summit. The Summit, held in Charleston, South Carolina, was a venue to share the impact of Cancer Prevention & Control’s lung cancer screening and survivorship programs. The WV Lung Cancer Project, funded by the Patient Advocate Foundation, aims to increase lung cancer screening, particularly among low-income and limited resourced individuals across WV. It was highlighted in an oral presentation by our partner, Shonta Chambers. The Bridge Program seeks to improve the coordination of care and decrease the consequences of lung cancer treatment for patients in the mountain state. Abby Starkey, MS, of Cancer Prevention and Control and Adrienne Duckworth, MSN, of the Mary Babb Randolph Cancer Center presented a poster highlighting its success. It has served 40 patients and identified more than 100 unmet needs of lung cancer survivors who have completed treatment. The program has also referred patients to more than 70 community resources, social services, and other health care providers.
Photo: (l-r) Jim Keresztury (Cancer Prevention & Control); Shonta Chambers (Patient Advocate Foundation); Stephenie Kennedy, Amie Muraski and Abby Starkey (Cancer Prevention & Control); and Adrienne Duckworth (Mary Babb Randolph Cancer Center)
WVU professor of Occupational and Environmental Health Sciences recently spoke with Public News Service about the cancellation of a study investigating the health impacts of mountaintop removal and other surface mining. Read the full story online.
Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years—silently growing, spreading and invading other organs—and by the time they’re detected, they may be so advanced that the patient’s prognosis is poor and her treatment options few. Valerie Galvan Turner, a gynecologic oncologist at the West Virginia University Cancer Institute, has opened a randomized clinical trial to assess whether a novel supplemental treatment can help chemotherapy and radiation fight these dangerous forms of cancer better.